Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial

NCT01678534 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Allogenic mesenchymal stem cells from adipose tissue
DRUG: Placebo

Sponsor

Instituto de Investigación Hospital Universitario La Paz